Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Longevity Health Holdings ( (XAGE) ) has issued an update.
On May 27, 2025, Longevity Health Holdings announced the successful sale of 479,621 shares of its common stock through its at-the-market equity offering, raising approximately $1.96 million. This financing is expected to extend the company’s cash runway into the first quarter of fiscal year 2026, supporting its planned merger with 20/20 BioLabs and the continued delivery of innovative longevity products.
More about Longevity Health Holdings
Longevity Health Holdings, Inc., also known as XAGE, is a company focused on advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition. The company offers regenerative technologies for skin and hair health, including Carmell Secretome and Elevai Exosomes, which are derived from human platelets and stem cells, respectively.
Average Trading Volume: 627,763
Technical Sentiment Signal: Sell
Current Market Cap: $2.64M
For detailed information about XAGE stock, go to TipRanks’ Stock Analysis page.